In addition, a robust DEME-based prognostic signature including HPRT1, PLOD2, ASNS, TXNRD1, CYP27B1, and FUT6 was constructed based on the TCGA HNSCC cohort. This evidence concerns the gene FUT6 and head and neck squamous cell carcinoma.